Monthly Archives: October 2022

Making intubation safer for the most fragile babies

Posted on 31 October 2022 by Keith Barrington

Many, many years ago, when I was a young trainee physician, we learned almost everything “on the job”. I can’t remember the first patient I intubated, but there were no mannequins, and no simulations, the phrase “see one, do one, … Continue reading →

Posted in Neonatal Research | Tagged , | 3 Comments

Time to stop placebo injections in neonatal research projects

Posted on 27 October 2022 by Keith Barrington

Randomized controlled trials are the bedrock of evidence-based medicine. If a treatment has a good theoretical rationale, and preclinical data showing efficacy, the only way to prove efficacy in the human is to randomise patients to the treatment, compared to … Continue reading →

Posted in Neonatal Research | Tagged , , , | 2 Comments

Protein pump inhibitors cause coeliac disease and asthma, and they are unnecessary.

Posted on 24 October 2022 by Keith Barrington

OK, that title is perhaps slightly too definite, the publications that I wanted to discuss are observational studies, which can only prove associations, but it would be hard to perform the prospective controlled trials that would be necessary to prove … Continue reading →

Posted in Neonatal Research | Tagged | Leave a comment

Reducing pain from retinopathy screening

Posted on 3 October 2022 by Keith Barrington

Retinopathy screening is undoubtedly painful for preterm babies, formal evaluation with PIPP scores routinely exceed 10 during screening, and may exceed 14, meaning moderate to severe pain. As a planned procedure there is always opportunity for pre-emptive analgesia prior to … Continue reading →

Posted in Neonatal Research | Tagged , | Leave a comment